Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🚫 This provider appears on the OIG List of Excluded Individuals/Entities (LEIE)
Exclusion type: 1128b4 · Date: 20240620 · State: NC
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
980
Total Claims
$921K
Drug Cost
194
Beneficiaries
$4,749
Cost/Patient
Risk Score Breakdown 27/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
+40%
Opioid rate vs peers
1.8% vs 1.3% avg
+18%
Cost per patient vs peers
$4,749 vs $4,034 avg
+255%
Brand preference vs peers
33.4% vs 9.4% avg
Opioid Prescribing
1.8%
Opioid Rate
18
Opioid Claims
$2,681
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 323 claims · $847K
Generic: 643 claims · $74K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Lamotrigine | 17 | $38K |
| Eslicarbazepine Acetate | 25 | $37K |
| Perampanel | 48 | $37K |
| Lacosamide | 29 | $32K |
| Lamotrigine | 14 | $31K |
| Erenumab-Aooe | 22 | $26K |
| Topiramate | 15 | $24K |
| Levetiracetam | 15 | $19K |
| Atogepant | 15 | $17K |
| Lacosamide | 38 | $11K |
| Divalproex Sodium | 21 | $10K |
| Carbamazepine | 30 | $5,642 |
| Oxcarbazepine | 18 | $5,458 |
| Levetiracetam | 55 | $3,068 |
| Carbidopa/Levodopa | 28 | $1,262 |
Prescribing Profile
21
Unique Drugs
27.0
Anomaly Score
Patient Profile
59
Avg Age
61%
Female
1.39
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About